Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 141942

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2022 | Month : October | Volume : 16 | Issue : 10 | Page : PC16 - PC19 Full Version

Splenectomy in Sickle Cell Haemoglobinopathies from a Tertiary Hospital of Southern Odisha: A Retrospective Study


Published: October 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/57815.17029
Abinash Kumar Panda, Bhupapati Bhusan Das, B Swagat Kumar Subudhi, Indrajeet Padhy

1. Assistant Professor, Department of Paediatric Surgery, SCB Medical College, Cuttack, Odisha, India. 2. Associate Professor, Department of General Surgery, SLN Medical College, Koraput, Odisha, India. 3. Assistant Professor, Department of General Surgery, SLN Medical College, Koraput, Odisha, India. 4. Senior Resident, Department of General Surgery, SLN Medical College, Koraput, Odisha, India.

Correspondence Address :
Dr. Abinash Kumar Panda,
QR No A/16, Doctors Colony, Svppgip, Sishu Bhawan,
Chandini Chowk, Cuttack, Odisha, India.
E-mail: dr.abinashpanda@gmail.com

Abstract

Introduction: Sickle Cell Disease (SCD) is a common haemoglobinopathy, where spleen is considered to be the first organ to be involved. Although it initially undergoes enlargement, but most often there occurs autosplenectomy. But in some cases, there is persistence of splenomegaly which may be associated with various complications. In these situations, splenectomy is considered as a good option to mitigate all these morbidities.

Aim: To analyse the effect of splenectomy on haematological parameters and complications in patients of SCD in postoperative period.

Materials and Methods: This was a retrospective study conducted at SLN Medical College and Hospital, Koraput, Odisha, India, from April 2019 to March 2021. Total 42 patients of SCD underwent splenectomy. The haematological parameters {Haemoglobin (Hb), Total Leukocyte Count (TLC) and Total Platelet Count (TPC)} and blood transfusion needs were compared in preoperative and postoperative periods and analysed statistically with Student’s t-test.

Results: Primary indication of splenectomy was hypersplenism 31 (73.8%) followed by splenic sequestration crisis in 8 patients (19.05%) and splenic abscess in 3 patients (7.1%). Postsplenectomy haemoglobin improvement was around 5.17 gm% (p-value<0.001). Postoperative complication was also minimal, seen in only eight patients, it was mostly due to surgical site infection (n=6) and fever (n=8). Preoperative blood transfusion rate was 9.07±1.92. Blood transfusion requirement rates were also drastically reduced to 0.5±0.707 postsplenectomy in these patients (p-value<0.001).

Conclusion: Following splenectomy, the need of blood transfusion was grossly reduced and also, the incidence of its complication was reduced.

Keywords

Hypersplenism, Sickle cell diseases, Splenomegaly

The Sickle Cell Disease (SCD) is one of the common haemoglobinopathies characterised by an inherited structural abnormality of haemoglobin with autosomal recessive inheritance (1). There is a mutation that leads to a single change in amino acid of haemoglobin beta chain i.e. glutamic acid is replaced with valine in 6th position (1). Its incidence is high, where the consanguineous marriage rate is high. Mostly the first organ to be affected in SCD is spleen. Initially it is enlarged in first few years of life, but later on due to repeated microvascular occlusion it undergoes gradual progressive fibrosis leading to autosplenectomy (2). It is frequently associated with complications like episodes of acute splenic sequestration crisis, hypersplenism, massive splenic infarction and splenic abscess (3). The life-long prevalence of acute splenic sequestration ranges from 7% to 30% according to Topley JM et al., (4), Powell RW et al., (5), Brousse V et al., (6). It is considered to be the second common cause of mortality in SCD following infection (4),(5).

Hypersplenism is characterised by enlarged spleen, causing rapid and premature destruction of blood cells of all lineages (7). Though, splenic abscess is rare in SCD but remains a diagnostic challenge as clinical features resembles to Vaso-occlusive crisis. Differentiating between them is important as massive splenic infarction can be managed conservatively leading to autosplenectomy (8). Sometimes there is persistence of spleen enlargement even to adulthood. It may be accompanied by increased morbidity and mortality (8). Elective splenectomy either open or laparoscopic is considered to be an effective measure to contain it. Study by Ghmaird A et al., revealed that following splenectomy, the blood transfusion requirement was grossly declined (9). Mishra B et al., in his study also concluded that elective splenectomy in SCD patients can minimise the morbidity of the disease like repeated hospitalisation, blood transfusion, living with huge spleen and its accompanying symptoms and complications (10). As the natural history of the spleen in SCD leads to autosplenectomy, in the majority of cases no surgical procedure is required.

The role of splenectomy arises whenever there is evidence of sustained hypersplenism or any life-threatening conditions like acute splenic sequestration occurs (11). The most important question regarding splenectomy here is to what degree the surgical removal of the spleen will further increase the risk of life-threatening infection and the ideal age for operation to be performed. There is no clear answer to this question. This study was conducted with an aim to review the experience in the management of SCD with massive splenomegaly and to analyse the effect of splenectomy on haematological parameters and complication in patients of SCD in postoperative period in this tribal belt of Southern Odisha, where the prevalence of SCD is more and there is more instances of patients with persistent huge splenomegaly.

Material and Methods

This was a retrospective study carried out in the patients of SCD, who underwent splenectomy in the Department of General Surgery, SLN Medical College, Koraput, Odisha, India, from April 2019 to March 2021. Data was collected from hospital record section and analysed in April 2022. Approval from Institutional Ethical Committee (IEC) was obtained (03-IEC/2022 SLN MCH). It included all the patients of SCD (n=42) who were admitted for splenectomy in the department and after obtaining informed consent during the stated period of study.

Inclusion criteria: All SCD patients with persistent splenomegaly having features of hypersplenism, sequestration crisis, splenic abscess or huge splenomegaly were included in this study.

Exclusion criteria: 1) Patients of SCD not associated with above mentioned complications, 2) The very sick patients who were not fit for surgery, 3) SCD patients with evidence of shrinking spleen size, 4) Associated with severe co-morbidity conditions were excluded from the study.

The patients were initially diagnosed and evaluated in Haematology Department, the diagnosis was on the basis of high performance liquid chromatography test and haemoglobin electrophoresis. Ultrasonogram/Computed Tomography (CT) scan of the abdomen and pelvis was done to see the spleen size, any other splenic pathology like infarction or abscess, or any incidental findings of cholelithiasis and for other abdominal pathology; if any. All the patients were vaccinated against Pneumococci, Haemophilus influenzae type B and Meningococci, minimum 2 to 3 weeks prior to surgery. Preoperative blood transfusion was required in all patients to bring the haemoglobin status to optimum for surgery. Open splenectomy was preferred in all of the patients, due to lack of expertise in advanced minimal invasive surgery. The immediate and early postoperative period was monitored closely for any complications. Patients were discharged on 6th-14th postoperative days. They were advised regarding vaccination schedule in postoperative period. The follow-up was done for 12 months after the surgery. Demographic data like age at surgery, sex, indication of splenectomy, preoperative and postoperative haematological parameters like Hb, TLC and TPC, frequency of blood transfusion and development of any complication or hospitalisation in the postsurgery period were noted.

Statistical Analysis

The preoperative and postoperative findings were compared by Student’s t-tests and p-value was calculated using Statistical Package for the Social Sciences (SPSS) software version 24.0.

Results

A total of 42 patients were included in this study. The mean age of subjects were 8.4±6.80 years with 71.43% of the patients presenting in the age group of <10 years (Table/Fig 1).

The primary indication of splenectomy was the repeated need of blood transfusion and hypersplenism in 31 patients (73.8%) (Table/Fig 2).

Splenomegaly was found in all patients with average size of 12.5±2.3 cm as measured by ultrasonography.

All the patients had undergone open splenectomy. Six patients (14.3%) had cholecystectomy together with splenectomy. Out of these three were symptomatic and rests of the patients were asymptomatic with multiple gall bladder calculi. Forty patients (95.2%) needed blood transfusion during the operation and 2 (4.8%) patients needed no blood transfusion. There was no mortality and postoperative complications were paralytic ileus in one patient and fever in eight patients (19.04%).

Average operative duration was 1.5±0.62 hours. No intraoperative mortality was recorded. Mean length of postoperative hospital stay was 7.4±3.6 days. Surgical site infection was found in six patients. Postoperatively eight patients developed fever that was managed conservatively.

In the 12 months postoperative follow-up, average haemoglobin was 10.57±0.69 gm% with a mean increase of 5.17±1.03 gm% as compared to preoperative state (p-value <0.001) for all three haematological parameters (Table/Fig 3).

Respiratory tract infection requiring hospitalisation was seen in three patients, in the 12 months follow-up period and they were managed with standard antibiotics. Painful crisis was seen in one patient on 54th postoperative day and it was managed with adequate analgesics and maintaining good hydration status. No record of Overwhelming Postsplenectomy Infection (OPSI) was noticed. When the blood transfusion was considered, preoperatively it was 9.07±1.92 blood units per year, while median rate of blood transfusion for 1st year postoperative and 2nd year postoperative was 0 and 1 respectively (p-value <0.001).

Discussion

Acute Splenic Sequestration Crisis (ASSC), an important complication of SCD, results from the rapid sequestration of red blood cells in the spleen. It is the second leading cause of death after infection in the first decades of life (12). This study revealed that eight patients had attack of ASSC (19.05%). Commonly ASSCs are seen in infants and young children, commonly between 5 months and 2 years of age (4),(5),(12). However, in present study the older children were also suffered from ASSC (mean 8.4 years). Though exact cause is not known, the persistence of splenomegaly even in older age group is considered to be one of the contributing factors (13),(14).

Hypersplenism is classically defined as splenomegaly with any combination of anaemia, thrombocytopenia, neutropenia (pancytopenia if all three) with compensatory bone marrow hyperplasia for a sustained period, and improvement after splenectomy (7). Hypersplenism was the main indication for splenectomy in present study patients. Various modalities of treatment have been advocated for hypersplenism like chronic blood transfusions, partial splenectomy, percutaneous intraluminal occlusion of the splenic artery, and embolic therapy (15),(16),(17). The main aim of these principles of treatment is to reduce the risk of OPSI, but each modality has its own limitation. However, chronic and multiple blood transfusion has risk of alloimmunisation, transmission of blood-borne infections and iron overload (18). Again patients with iron overload disorders are susceptible to lethal infection with bacteria like Vibrio vulnificus, Yersinia enterocolitica and Escherichia coli, Bacillus, Listeria and virus like Parvo virus, Cytomegalovirus and Hepatitis B and C (19). Three patients in present study had past history of suffering from septicaemia with pathogen like Escherichia coli. Apart from this repeated hospitalisation and limited availability of blood, makes it more bothersome to both parents and children.

Again, huge splenomegaly may increase the chance of splenic injury in a trivial trauma. Partial splenic embolisation may be one of the treatment options of hypersplenism, but it is unsuitable form of treatment for patients with SCD because of its associated complications (20),(21). So, it can be said that in patients of hypersplenism, splenectomy is highly useful in decreasing their transfusion requirements and alleviating the discomfort from mechanical pressure of the enlarged spleen (14).

Splenectomy is considered to be a safe, effective and better option in the management of patients of sickle cell haemoglobinopathies with splenic complications in this region. According to the different studies, the risk of postsplenectomy sepsis is found to be increased substantially, if splenectomy is performed before 4 years of age (22),(23). However, in present study overwhelming postsplenectomy sepsis was not noticed in the 12 months postoperative follow-up period. Splenic abscess is not a common entity. Due to early autosplenectomy in patients with SCD, the chance of development of splenic abscess further reduces. In a setting of functional asplenia with repeated splenic infarction, there occurs seedling of infective agent in the persistently enlarged spleen, making them more prone to abscess formation (24). The overall incidence of splenic abscess is 0.14- 0.7% in necropsy specimen (25).

A variety of organisms can cause splenic abscess including Staphylococci, Streptococci, and gram negative bacilli like Salmonella and E. coli. Sepsis is the most common predisposing factor for splenic abscess. Three patients undergone splenectomy for splenic abscess in present study and all were adults. They presented with fever and abdominal tenderness. Multilocular splenic abscess were found in the above patients of present study group and the size ranged from 3 cm to 12.5 cm. It is recommended that in unilocular abscesses of <3 cm in size, drainage under radiological guidance with proper antibiotic coverage is a good and safe option (24). When abscess size is >10 cm or non surgical approach is not helpful, splenectomy has been considered to be next method of treatment (13),(26).

In present study, the mean length of hospital stay after the operation was 7.4±3.6 days, compared to other study where it was three days for laparoscopic splenectomy (27). When the haematological parameters were compared it was found that, the mean preoperative Hb was 5.4±0.63 gm/dL and postoperatively it was increased to 10.57±0.69 gm% (p-value <0.001). According to Lesher AP et al., there was 38% decrease in the number of units transfused during first six months postsplenectomy and a 45% decrease during 6 to 12 months postsplenectomy and all the haematologic parameters remained stable or improved (22). Red blood cell turnover was decreased as evidenced by raised haematocrit and decreased reticulocytes count after the splenectomy. All these above factors indicated that the survival of the transfused red cells were greatly improved (22). Another Saudi Arbian study by Al Salem AH clearly showed that the postoperative haematocrit and reticulocytes significantly improved in children following splenectomy for hypersplenism (13). Svarch E et al., also noticed that haemoglobin concentration was significantly improved (6.0 vs. 7.7; p-value=0.01) along with reduction in blood transfusion after partial splenectomy for acute splenic sequestration (28). In present study, there was history of one unit transfusion in one patient only which clearly demonstrated the advantage of splenectomy in SCD patients.

There are several advantages of splenectomy in SCD apart from improvement in haematological variables. Due to improved red cell half life, haematopeotic pressure over bone marrow is greatly reduced (29). There is relief of abdominal heaviness from enlarged spleen. Patient develops a good appetite as gastric compression by spleen is no more present. They are not transfusion dependent. All these factors help in regaining, a well appreciated growth in postsplenectomy patients (30). With availability of good surgical technique and safe anaesthetic option and with above mentioned advantages following splenectomy, it can be opined that elective splenectomy in SCD with persistent enlarged spleen or having sequestration crisis is very much safe and beneficial to these patients.

It is also supported by various studies (13),(22),(29). However, this study was conducted in an area where rate of consanguineous marriage is very high and the incidence of persistence of splenomegaly in SCD is also more. Due to poor standard of living, conservative approach to spleen could not be considered as a better option to them.

Limitation(s)

The limiting factor in this study was the small study population, and study involving only a limited geographical area. It will be better to study a large numbers of patients from a wider geographical area, with variable presentation to reach an acceptable inference.

Conclusion

With good perioperative care, well planned vaccination schedule and appropriate antibiotic prophylaxis was required. An elective splenectomy in SCD is not only considered to be safe but also reduces the morbidity and life-threatening complications associated with it. It also significantly reduces the need of repeated blood transfusion and its related disadvantages. The incidence of OPSI is also very minimal with adequate vaccination coverage.

References

1.
Ingram VM. Gene mutations in human haemoglobin: The chemical difference between normal and sickle cell haemoglobin. Nature. 1957;180(4581):326-28. [crossref] [PubMed]
2.
Serjeant GR. Evolving locally appropriate models of care for Indian sickle cell disease. The Indian J Med Res. 2016;143 (4):405-13. Doi:10.4103/0971-5916.184282. [crossref] [PubMed]
3.
Serjeant GR, Chin N, Asnani MR, Serjeant BE, Mason KP, Hambleton IR, et al. Causes of death and early life determinants of survival in homozygous sickle cell disease: The Jamaican cohort study from birth. PLoS One. 2018;13(3):e0192710. Doi: 10.1371/journal.pone.0192710. PMID: 29494636; PMCID: PMC5832208. [crossref] [PubMed]
4.
Topley JM, Rogers DW, Stevens MC, Serjeant GR. Acute splenic sequestration and hypersplenism in the first five years in homozygous sickle cell disease. Archives of Disease in Childhood. 1981;56(10):765-69. [crossref] [PubMed]
5.
Powell RW, Levine GL, Yang YM, Mankad VN. Acute splenic sequestration crisis in sickle cell disease: Early detection and treatment. Journal of Pediatric Surgery. 1992;27(2):215-19. [crossref] [PubMed]
6.
Brousse V, Elie C, Benkerrou M, Odièvre MH, Lesprit E, Bernaudin F, et al. Acute splenic sequestration crisis in sickle cell disease: Cohort study of 190 paediatric patients. British J Haematology. 2012;156(5):643-48. [PubMed] [Google Scholar]. [crossref] [PubMed]
7.
Dameshek W. Hypersplenism. Bull N Y Acad Med. 1955;31(2):113-36. PMID: 13230762; PMCID: PMC1804426.
8.
Al-Salem AH. Splenic complications of sickle cell anaemia and the role of splenectomy. International Scholarly Research Notices. 2011;2011:864257. Doi: 10.5402/2011/864257. Epub 2010 Oct 31. PMID: 22084706; PMCID: PMC3200071. [crossref] [PubMed]
9.
Ghmaird A, Alnoaiji MM, Al-Blewi S, Zaki S, El-Lewi A, Ahmad N. Splenectomy in patients with sickle cell disease in Tabuk. Open Access Macedonian J Med Sci. 2016;4(1):107. http://dx.doi.org/10.3889/oamjms.2016.034. [crossref] [PubMed]
10.
Mishra B, Nayak MK, Mishra S, Das I. Splenectomy in sickle cell haemoglobinopathies. Int Sur J. 2019;6(4):1371-75. [crossref]
11.
Brousse V, Buffet P, Rees D. The spleen and sickle cell disease: The sick (led) spleen. British J Haematology. 2014;166(2):165-76. https://doi:10.1111/bjh.12950. [crossref] [PubMed]
12.
Emond AM, Collis R, Darvill D, Higgs DR, Maude GH, Serjeant GR, et al. Acute splenic sequestration in homozygous sickle cell disease: Natural history and management. The J Paediatrics. 1985;107(2):201-06. ISSN 0022-3476, https:// doi.org/10.1016/S0022-3476(85)80125-6. [crossref] [PubMed]
13.
Al-Salem AH. Indications and complications of splenectomy for children with sickle cell disease. J Paediat Sur. 2006;41(11):1909-15.http://dx.doi. org/10.1016/j.jpedsurg.2006.06.020. PMID :17101369. [crossref] [PubMed]
14.
Al Salem AH, Qaisaruddin S, Nasserullah Z, Al Dabbous I, Abu Srair H, Jam’a A. Splenectomy and acute splenic sequestration crises in sickle cell disease. Paediat Sur Int. 1996;11(1):26-28. https://doi.org/10.1007/BF00174580. [crossref] [PubMed]
15.
Pringle KC, Spigos DG, Tan WS. Partial splenic embolization in the management of thalassemia major. J Paediat Sur. 1982:17(6):884-91. [crossref] [PubMed]
16.
Witte CL, Van Wyck DB, Witte MH, Corrigan JJ, Zukoski CF, Pond GD, et al. Ischaemia and partial resection for control of splenic hyperfunction. Br J Sur. 1982;69(9):531-35. [crossref] [PubMed]
17.
Alwmark AN, Bengmark ST, Gullstrand P, Joelsson B, Lunderquist AN, Owman TO. Evaluation of splenic embolization in patients with portal hypertension and hypersplenism. Ann Sur. 1982;196(5):518-24. [crossref] [PubMed]
18.
Davies SC, McWilliam AC, Hewitt PE, Devenish A, Brozovic M. Red cell alloimmunization in sickle cell disease. British Journal of Haematology. 1986;63(2):241-45. https://doi.org/10.1111/j.1365-2141.1986.tb05546.x. [crossref] [PubMed]
19.
Khan FA, Fisher MA, Khakoo RA. Association of hemochromatosis with infectious diseases: expanding spectrum. Int J Infect Dis. 2007;11(6):482-87. https://doi. org/10.1016/j.ijid.2007.04.007. [crossref] [PubMed]
20.
Castaneda-Zuniga WR, Hammerschmidt DE, Sanchez RA, Amplatz KU. Nonsurgical splenectomy. Am J Roentgenology. 1977;129(5):805-11. [crossref] [PubMed]
21.
Spigos DG, Jonasson O, Mozes M, Capek V. Partial splenic embolization in the treatment of hypersplenism. Am J Roentgenology. 1979;132(5):777-82. [crossref] [PubMed]
22.
Lesher AP, Kalpatthi R, Glenn JB, Jackson SM, Hebra A. Outcome of splenectomy in children younger than 4 years with sickle cell disease. J Paediat Sur. 2009;44(6):1134-38. Doi: 10.1016/j.jpedsurg.2009.02.016. PMID: 19524729. [crossref] [PubMed]
23.
Mills ML. Life-threatening complications of sickle cell disease in children. JAMA. 1985;254(11):1487-91. Doi: 10.1001/jama.1985.03360110077028. [crossref] [PubMed]
24.
Al-Salem AH, KadappaMallapa K, Qaisaruddin S, Al-Jam’a A, Elbashir A. Splenic abscess in children with sickle-cell disease. Paediat Sur Int. 1994;9(7):489-91. https://doi.org/10.1007/BF00179448. [crossref]
25.
Gadacz TR. Splenic abscess. World J Sur. 1985;9(3):410-15. https://doi. org/10.1007/BF01655275. [crossref] [PubMed]
26.
Abdul Rehman A, Shazia K, China S. Splenic abscess: outcome and prognostic factors. J Coll Physicians Surg Pak. 2008;18(12):740-43. PMID: 19032885.
27.
Rescorla FJ, Breitfeld PP, West KW, Williams D, Engum SA, Grosfeld JL, et al. A case controlled comparison of open and laparoscopic splenectomy in children. Surgery. 1998;124(4):670-76. http://dx.doi.org/10.1067/msy.1998.91223 PMID: 9780987. [crossref] [PubMed]
28.
Svarch E, Nordet I, Valdes J. Partial splenectomy in children with sickle cell disease. Haematologica. 2003;88:222-23. PMID: 12604414.
29.
Sprague CC, Paterson JC. Role of the spleen and effect of splenectomy in sickle cell disease. Blood. 1958;13(6):569-81. PMID: 13535936. [crossref] [PubMed]
30.
Singhal A, Thomas P, Kearney T, Venugopal S, Serjeant G. Acceleration in linear growth after splenectomy for hypersplenism in homozygous sickle cell disease. Archives of Dis in Childhood. 1995;72(3):227-29. Doi: 10.1136/adc.72.3.227. PMID: 7741569. [crossref] [PubMed]

DOI and Others

DOI: 10.7860/JCDR/2022/57815.17029

Date of Submission: May 16, 2022
Date of Peer Review: Jun 21, 2022
Date of Acceptance: Aug 05, 2022
Date of Publishing: Oct 01, 2022

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: May 22, 2022
• Manual Googling: Jul 29, 2022
• iThenticate Software: Aug 04, 2022 (18%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com